A First-in-Human Study Using BDC-4182 as a Single Agent in Advanced Gastric and Gastroesophageal Cancer
Clinical trial NCT06921837 · RECRUITING
Trial details
- NCT number
- NCT06921837
- Sponsor
- Bolt Biotherapeutics, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-05-26
- Primary completion
- 2027-05-01
- Enrollment
- 122
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.